CD4+ TEG011_CD8α cells produced a significantly higher IFNγ level compared to CD4+ TEG011, which was equivalent to those of TEG011 bulk cells against all tumor targets, without affecting healthy cells. This evidence concerns the gene CD4 and neoplasm.